Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Mesoblast (MESO) Forecast
NewsEarningsMesoblast (MESO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Mesoblast Stock Price, Quotes and Forecasts | NASDAQ:MESO | Benzinga
Explore Mesoblast stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MESO.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mesoblast (MESO) stock?
You can purchase shares of Mesoblast (NASDAQ:MESO) through any online brokerage.
Who are Mesoblast (MESO) competitors?
Other companies in Mesoblast’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Centessa Pharmaceuticals (NASDAQ:CNTA), Ascentage Pharma Group (NASDAQ:AAPG), Arcutis Biotherapeutics (NASDAQ:ARQT) and Arrowhead Pharma (NASDAQ:ARWR).
What is the forecast, or price target, for Mesoblast (MESO) stock?
Mesoblast has a consensus price target of $12.50.
What is the current price for Mesoblast (MESO)?
The stock price for Mesoblast (NASDAQ: MESO) is $13.95 last updated March 6, 2025 at 12:56 PM EST.
Does Mesoblast (MESO) pay a dividend?
There are no upcoming dividends for Mesoblast.
When is Mesoblast (NASDAQ:MESO) reporting earnings?
Mesoblast’s H1 earnings are confirmed for Wednesday, February 26, 2025.
Is Mesoblast (MESO) going to split?
There is no upcoming split for Mesoblast.
What sector and industry does Mesoblast (MESO) operate in?
Mesoblast is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.